Tanaka Capital Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Tanaka Capital Management’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-189,030	Closed	-$1.52M	–	48
2019 Q2	$1.52M	Sell	189,030 -3,190	-2%	-$21.4K	4.64%	8
2019 Q1	$1.05M	Sell	192,220 -6,675	-3%	-$28.7K	3.16%	12
2018 Q4	$710K	Hold	198,895	–	–	2.26%	17
2018 Q3	$1.75M	Buy	198,895 +700	+0.4%	+$6.7K	4.07%	7
2018 Q2	$1.92M	Buy	198,195 +21,455	+12%	+$198K	4.6%	8
2018 Q1	$1.44M	Buy	176,740 +48,430	+38%	+$384K	3.44%	11
2017 Q4	$903K	Buy	128,310 +47,605	+59%	+$277K	2.06%	16
2017 Q3	$416K	Hold	80,705	–	–	0.93%	26
2017 Q2	$756K	Sell	80,705 -10,760	-12%	-$115K	1.73%	19
2017 Q1	$1.75M	Buy	+91,465	New	+$1.73M	3.85%	9

Other funds holding NTRP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tanaka Capital Management's NTRP Position: Q3 2019 in Review

Tanaka Capital Management sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 189,030 shares — an estimated $1.52M sold.

Tanaka Capital Management first reported a position in NTRP in Q1 2017 and held it in 10 quarters. The position peaked at $1.92M in Q2 2018. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

Tanaka Capital Management reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
Tanaka Capital Management sold 189,030 Neurotrope, Inc. Common shares in Q3 2019, an estimated $1.52M.
Tanaka Capital Management first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 10 quarters.
Tanaka Capital Management's Neurotrope, Inc. Common position peaked at $1.92M in Q2 2018.
29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on Tanaka Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.